» Articles » PMID: 34840988

An Update of Medical Nutrition Therapy in Gestational Diabetes Mellitus

Overview
Journal J Diabetes Res
Publisher Wiley
Specialty Endocrinology
Date 2021 Nov 29
PMID 34840988
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Gestational diabetes mellitus (GDM) is a serious and frequent pregnancy complication that can lead to short and long-term risks for both mother and fetus. Different health organizations proposed different algorithms for the screening, diagnosis, and management of GDM. Medical Nutrition Therapy (MNT), together with physical exercise and frequent self-monitoring, represents the milestone for GDM treatment in order to reduce maternal and fetal complications. The pregnant woman should benefit from her family support and make changes in their lifestyles, changes that, in the end, will be beneficial for the whole family. The aim of this manuscript is to review the literature about the Medical Nutrition Therapy in GDM and its crucial role in GDM management.

Citing Articles

Microscopic changes and gross morphology of placenta in women affected by gestational diabetes mellitus in dietary treatment: A systematic review.

Molitierno R, Imparato A, Iavazzo N, Salzillo C, Marzullo A, Lagana A Open Med (Wars). 2025; 20(1):20251142.

PMID: 39958976 PMC: 11826244. DOI: 10.1515/med-2025-1142.


Correlations Between Gut Microbiota Composition, Medical Nutrition Therapy, and Insulin Resistance in Pregnancy-A Narrative Review.

Enache R, Rosu O, Profir M, Pavelescu L, Cretoiu S, Gaspar B Int J Mol Sci. 2025; 26(3).

PMID: 39941139 PMC: 11818759. DOI: 10.3390/ijms26031372.


Associations Between Carbohydrate Intake Behaviours and Glycaemia in Gestational Diabetes: A Prospective Observational Study.

Smith R, Borg R, Wong V, Russell H, Mak K Nutrients. 2025; 17(3).

PMID: 39940258 PMC: 11819901. DOI: 10.3390/nu17030400.


Higher gut Bacteroidetes and Actinobacteria population in early pregnancy is associated with lower risk of gestational diabetes in the second trimester.

Mousavi S, Momeni N, Chiti H, Mahmoodnasab H, Ahmadi M, Heidarzadeh S BMC Pregnancy Childbirth. 2025; 25(1):106.

PMID: 39901086 PMC: 11789361. DOI: 10.1186/s12884-025-07192-0.


Upregulation of OGT-mediated EZH2 O-GlcNAcylation Promotes Human Umbilical Vein Endothelial Cell Proliferation, Invasion, Migration, and Tube Formation in Gestational Diabetes Mellitus.

Qiu Y, Yu W, Zhang X, Zhang M, Ni Y, Lai S Cell Biochem Biophys. 2025; .

PMID: 39751742 DOI: 10.1007/s12013-024-01655-5.


References
1.
Santamaria A, Di Benedetto A, Petrella E, Pintaudi B, Corrado F, DAnna R . Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial. J Matern Fetal Neonatal Med. 2015; 29(19):3234-7. DOI: 10.3109/14767058.2015.1121478. View

2.
Metzger B, Lowe L, Dyer A, Trimble E, Chaovarindr U, Coustan D . Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008; 358(19):1991-2002. DOI: 10.1056/NEJMoa0707943. View

3.
Blumer I, Hadar E, Hadden D, Jovanovic L, Mestman J, Murad M . Diabetes and pregnancy: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2013; 98(11):4227-49. PMC: 8998095. DOI: 10.1210/jc.2013-2465. View

4.
Yamamoto J, Kellett J, Balsells M, Garcia-Patterson A, Hadar E, Sola I . Gestational Diabetes Mellitus and Diet: A Systematic Review and Meta-analysis of Randomized Controlled Trials Examining the Impact of Modified Dietary Interventions on Maternal Glucose Control and Neonatal Birth Weight. Diabetes Care. 2018; 41(7):1346-1361. DOI: 10.2337/dc18-0102. View

5.
Santamaria A, Alibrandi A, Di Benedetto A, Pintaudi B, Corrado F, Facchinetti F . Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs. Am J Obstet Gynecol. 2018; 219(3):300.e1-300.e6. DOI: 10.1016/j.ajog.2018.05.018. View